ABELES JOHN H purchased 18.1% of their position (400K shares) of MEDITE CANCER DIAGNOSTICS, INC. on the open market
Open‑market purchase worth $30.0K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/10/2018ACC: 0001415889-18-001103
Director
Since Jul 2018
+400K
Net shares
Net buyer
$30.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
400K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+400K
Price / share
$0.07
Trade value
$30K
% of position
18.1%
7/3/2018
2.21M→2.61M
Total
Net shares
+400K
Net value
$30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/3/2018 | P · Purchase | +400K | $0.07 | $30K | 18.1% | 2.21M | 2.61M |
| Total | +400K | $30K | ||||||
Derivative Transactions0
No derivative transactions reported